Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.41 |
| ▸ | BCL9 | O00512 | 1/20 | 0.41 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5160750 | 1.00 | CYP2C19 (0.48) | CYP2C19CYP1A2ALDH1A1POLBTSHR | |
| Hydrochloric Acid SCHEMBL7744795 | 0.79 | CYP2C19 (0.46) | CYP2C19CYP1A2ALDH1A1POLBTSHR | |
| Hydrochloric Acid SCHEMBL7744797 | 0.79 | CYP2C19 (0.46) | CYP2C19CYP1A2ALDH1A1POLBTSHR | |
| SCHEMBL6667989 | 0.79 | TSHR (0.49) | CYP2C19CYP1A2ALDH1A1TSHRLOXL2 | |
| SCHEMBL3080086 | 0.79 | TSHR (0.49) | CYP2C19CYP1A2ALDH1A1TSHRLOXL2 | |
| SCHEMBL9724009 | 0.78 | FDPS (0.46) | CYP1A2ALDH1A1POLBTSHRLOXL2 | |
| SCHEMBL678471 | 0.78 | TSHR (0.52) | CYP2C19CYP1A2ALDH1A1TSHRLOXL2 | |
| SCHEMBL5343038 | 0.78 | BLM (0.56) | ALDH1A1TSHR | |
| SCHEMBL7908936 | 0.78 | SMN1; SMN2 (0.52) | CYP2C19CYP1A2ALDH1A1CES1 | |
| SCHEMBL7908766 | 0.78 | SMN1; SMN2 (0.52) | CYP2C19CYP1A2ALDH1A1CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753716-A1 | BASIC SALTS AND MONOHYDRATES OF CERTAIN ALPHA, BETA-PROPRIONIC ACID DERIVATIVE | Dr. Reddy's Laboratories Ltd. (IN) | 2007-02-21 | — | — | EP | disclosed |
| WO-2006001795-A1 | BASIC SALTS AND MONOHYDRATES OF CERTAIN ALPHA, BETA-PROPRIONIC ACID DERIVATIVE | DR. REDDY'S LABORATORIES LIMITED (IN) | 2006-01-05 | — | — | WO | disclosed |
| US-20050277693-A1 | Basic salts and monohydrates of certain alpha, beta-propionic acid derivative | DR. REDDY'S LABORATORIES LIMITED | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277693-A1 | Basic salts and monohydrates of certain alpha, beta-propionic acid derivative | SRM, PKD1, CA2 | CYP2C19 3621/4885CYP1A2 2951/4885ALDH1A1 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.